Achieve Life Sciences GAAP EPS of -$0.19 Beats by $0.11

Achieve Life Sciences press release (ACHV): Q1 GAAP EPS of -$0.19 beats by $0.11. - As of March 31, 2026, the Company's cash, cash equivalents, and marketable securities were $29.3 million, not including estimated net proceeds of approximately $168.6 million from the private...</

Achieve Life Sciences press release (ACHV): Q1 GAAP EPS of -$0.19 beats by $0.11. – As of March 31, 2026, the Company’s cash, cash equivalents, and marketable securities were $29.3 million, not including estimated net proceeds of approximately $168.6 million from the private…

acement, after deducting estimated agent fees and other expenses

Leave a Reply

Your email address will not be published. Required fields are marked *